{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:32:34Z","timestamp":1790627554932,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Centre, Poland","award":["SONATA 2015\/17\/D\/NZ4\/02284"],"award-info":[{"award-number":["SONATA 2015\/17\/D\/NZ4\/02284"]}]},{"name":"National Science Centre, Poland","award":["OPUS 11 2016\/21\/B\/NZ4\/00128"],"award-info":[{"award-number":["OPUS 11 2016\/21\/B\/NZ4\/00128"]}]},{"name":"Institute of Pharmacology Polish Academy of Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pharep.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T20:30:02Z","timestamp":1538857802000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model"],"prefix":"10.1007","volume":"71","author":[{"given":"Ewelina","family":"Rojewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharep.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrneurol.2013.180","article-title":"Reappraising neuropathic pain in humans\u2014how symptoms help disclose mechanisms","volume":"9","author":"Truini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0020","first-page":"14","article-title":"Truncal neuralgia in diabetic patients: an ignored cause of abdominal pain","volume":"4","author":"Lotfy","year":"2017","journal-title":"Edorium J Surg"},{"key":"10.1016\/j.pharep.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.2174\/0929867323666160607120124","article-title":"Targeting the microglial signaling pathways: new insights in the modulation of neuropathic pain","volume":"23","author":"Popiolek-Barczyk","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.04.014","article-title":"Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms","volume":"661","author":"Pabreja","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1159\/000354485","article-title":"CD8 + T cell-mediated cytotoxicity toward schwann cells promotes diabetic peripheral neuropathy","volume":"32","author":"Tang","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S1734-1140(13)71521-4","article-title":"Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies","volume":"65","author":"Zychowska","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2018.10.002_bib0050","article-title":"The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy","volume":"2015","author":"Zychowska","year":"2015","journal-title":"J Diab Res"},{"key":"10.1016\/j.pharep.2018.10.002_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2017.09.021","article-title":"Spinal CCL1\/CCR8 signaling interplay as a potential therapeutic target \u2013 evidence from a mouse diabetic neuropathy model","volume":"52","author":"Zychowska","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fimmu.2018.00494","article-title":"Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1523\/JNEUROSCI.0828-09.2009","article-title":"The liberation of fractalkine in the dorsal horn requires microglial cathepsin S","volume":"29","author":"Clark","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.expneurol.2011.09.012","article-title":"Microglial signalling mechanisms: Cathepsin S and Fractalkine","volume":"234","author":"Clark","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","article-title":"Chemokines and pain mechanisms","volume":"60","author":"Abbadie","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharep.2018.10.002_bib0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal\u2013glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11481-017-9729-6","article-title":"The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats","volume":"12","author":"Kwiatkowski","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.04.017","article-title":"Direct and indirect pharmacological modulation of CCL2\/CCR2 pathway results in attenuation of neuropathic pain \u2014 in vivo and in vitro evidence","volume":"297","author":"Piotrowska","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0095","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","volume":"31","author":"Van Steenwinckel","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0100","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1523\/JNEUROSCI.3016-07.2007","article-title":"Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain","volume":"27","author":"Zhang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1744-8069-5-48","article-title":"Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy","volume":"5","author":"Bhangoo","year":"2009","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/1742-2094-9-136","article-title":"Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain","volume":"9","author":"Zhang","year":"2012","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.pharep.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/ALN.0000000000001219","article-title":"Microglial inhibition influences XCL1\/XCR1 expression and causes analgesic effects in a mouse model of diabetic neuropathy","volume":"125","author":"Zychowska","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1\u03b1 mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1\u03b2 up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.07.005","article-title":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","volume":"64","author":"Kwiatkowski","year":"2016","journal-title":"Prog Neurol-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1401704","article-title":"Cutting edge: GPR35\/CXCR8 is the receptor of the mucosal chemokine CXCL17","volume":"194","author":"Maravillas-Montero","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00041","article-title":"G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease","volume":"6","author":"Divorty","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2011.00068","article-title":"GPR35 as a novel therapeutic target","volume":"2","author":"MacKenzie","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pharep.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2011.02.002","article-title":"Orthologue selectivity and ligand bias: translating the pharmacology of GPR35","volume":"32","author":"Milligan","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0150","first-page":"1","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Reggio","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neuropharm.2015.07.035","article-title":"The emerging pharmacology and function of GPR35 in the nervous system","volume":"113","author":"Mackenzie","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0160","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1074\/jbc.M113.508382","article-title":"Crucial positively charged residues for ligand activation of the GPR35 receptor","volume":"289","author":"Zhao","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2016.04.038","article-title":"Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation","volume":"108","author":"Resta","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2009.09.030","article-title":"Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain","volume":"623","author":"Mika","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1021\/acschemneuro.7b00226","article-title":"Analgesic properties of Opioid\/NK1 multitarget ligands with distinct in vitro profiles in naive and chronic constriction injury mice","volume":"8","author":"Starnowska","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2015.03.003","article-title":"Effects of chronic doxepin and amitriptyline administration in na\u00efve mice and in neuropathic pain mice model","volume":"294","author":"Mika","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0200","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","author":"Fukui","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2015.02.001","article-title":"The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level","author":"Tuboly","year":"2015","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(02)04228-2","article-title":"Kynurenic acid enhances electroacupuncture analgesia in normal and carrageenan-injected rats","volume":"966","author":"Zhang","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2018.10.002_bib0215","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bcp.2014.12.009","article-title":"Functional G-protein-coupled receptor 35 is expressed by neurons in the CA1 field of the hippocampus","volume":"93","author":"Alkondon","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082180","article-title":"GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapses","volume":"8","author":"Berlinguer-Palmini","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.10.002_bib0225","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","article-title":"G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast","volume":"60","author":"Cosi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0230","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M608019200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2007.10.197","article-title":"GPR35 is a functional receptor in rat dorsal root ganglion neurons","volume":"365","author":"Ohshiro","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2018.10.002_bib0240","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.febslet.2006.08.015","article-title":"A well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35","volume":"580","author":"Taniguchi","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharep.2018.10.002_bib0245","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2017.09.113","article-title":"The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer","volume":"493","author":"Guo","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2018.10.002_bib0250","series-title":"Evidence for the existence of a CXCL17 receptor distinct from GPR35","author":"Binti","year":"2018"},{"key":"10.1016\/j.pharep.2018.10.002_bib0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bph.14082","article-title":"GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?","volume":"175","author":"Park","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/abbs\/gmp051","article-title":"Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion","volume":"41","author":"Mu","year":"2009","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.pharep.2018.10.002_bib0265","article-title":"CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor","volume":"304","author":"Lee","year":"2013","journal-title":"Am J Physiol Metab"},{"key":"10.1016\/j.pharep.2018.10.002_bib0270","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.gastro.2010.10.009","article-title":"CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis","volume":"140","author":"Hiraoka","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2006.08.194","article-title":"VCC-1, a novel chemokine, promotes tumor growth","volume":"350","author":"Weinstein","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2018.10.002_bib0280","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.pain.2013.07.002","article-title":"Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons","volume":"154","author":"Zhang","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0285","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.bbadis.2018.07.032","article-title":"Pharmacological blockade of CXCR3 by (\u00b1)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - evidence from in vivo and in vitro studies","volume":"1864","author":"Piotrowska","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2018.10.002_bib0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-016-0652-1","article-title":"Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5\/ERK pathway in the trigeminal ganglion of mice","volume":"13","author":"Zhang","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.pharep.2018.10.002_bib0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jnc.13927","article-title":"The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain","volume":"141","author":"Montague","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0300","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.4049\/jimmunol.1102903","article-title":"CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity","volume":"188","author":"Burkhardt","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tins.2005.10.001","article-title":"Glia: novel counter-regulators of opioid analgesia","volume":"28","author":"Watkins","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0310","first-page":"297","article-title":"Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness","volume":"60","author":"Mika","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2018.10.002_bib0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.npep.2011.03.002","article-title":"The role of nociceptin and dynorphin in chronic pain: implications of neuro\u2013glial interaction","volume":"45","author":"Mika","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharep.2018.10.002_bib0320","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","article-title":"Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery","volume":"119","author":"Moroni","year":"2012","journal-title":"J Neural Trans"},{"key":"10.1016\/j.pharep.2018.10.002_bib0330","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0091-3057(98)00006-9","article-title":"Interactions between N-methyl-d-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats","author":"Bespalov","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2018.10.002_bib0335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","author":"Chess","year":"2007","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.pharep.2018.10.002_bib0340","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.17nr02235","article-title":"Galantamine-memantine combination for cognitive impairments due to electroconvulsive therapy, traumatic brain injury, and neurologic and psychiatric disorders: kynurenic acid and mismatch negativity target engagement","volume":"20","author":"Koola","year":"2018","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.pharep.2018.10.002_bib0345","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/jpet.111.189860","article-title":"Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid","author":"Banerjee","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2018.10.002_bib0350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(85)90685-7","article-title":"Effects of kynurenate on root potentials evoked by synaptic activity and amino acids in the frog spinal cord","author":"Elmslie","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2018.10.002_bib0355","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","article-title":"Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites","volume":"375","author":"Moroni","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0360","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0361-9230(95)02087-X","article-title":"Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain","volume":"39","author":"Wu","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2018.10.002_bib0365","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1570159X14666151113123221","article-title":"Memantine and kynurenic acid: current neuropharmacological aspects","volume":"14","author":"Majl\u00e1th","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2018.10.002_bib0375","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/j.1532-2149.2013.00305.x","article-title":"The l -kynurenine-probenecid combination reduces neuropathic pain in rats","volume":"17","author":"Pineda-Farias","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(92)90067-E","article-title":"Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice","volume":"212","author":"N\u00e4sstr\u00f6m","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0385","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(95)01063-7","article-title":"Time-related roles of excitatory amino acid receptors during persistent noxiously evoked responses of rat dorsal horn neurones","volume":"703","author":"Chapman","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2018.10.002_bib0390","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1021\/jm200999f","article-title":"Discovery of 2-(4-methylfuran-2(5 H)-ylidene)malononitrile and thieno[3,2- b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists","volume":"54","author":"Deng","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.002_bib0395","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/BJ20101287","article-title":"Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of \u03b2-arrestin-2 and activate G \u03b113","volume":"432","author":"Jenkins","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.pharep.2018.10.002_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314164","article-title":"G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium","volume":"86","author":"Yang","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharep.2018.10.002_bib0405","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/mol.110.066746","article-title":"Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and -Arrestin2 with antinociceptive activity","volume":"78","author":"Zhao","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0410","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2005.08.006","article-title":"Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test","volume":"390","author":"Yoon","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2018.10.002_bib0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3344\/kjp.2009.22.1.16","article-title":"The antiallodynic effects of intrathecal zaprinast in rats with chronic constriction injury of the sciatic nerve","volume":"22","author":"Do","year":"2009","journal-title":"Korean J Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0420","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1087057113475480","article-title":"Screening \u03b2-arrestin recruitment for the identification of natural ligands for orphan G-protein\u2013coupled receptors","volume":"18","author":"Southern","year":"2013","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.pharep.2018.10.002_bib0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pjnns.2014.11.002","article-title":"Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish association for the study of pain and the Polish neurological society \u2013 part two","volume":"48","author":"Szczudlik","year":"2014","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pjnns.2014.07.011","article-title":"Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish association for the study of pain and the Polish neurological society - part one","volume":"48","author":"Szczudlik","year":"2014","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0435","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mcn.2015.12.013","article-title":"Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","volume":"71","author":"Pilat","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharep.2018.10.002_bib0440","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0265021505001791","article-title":"Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test","volume":"23","author":"Yoon","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0445","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3344\/kjp.2005.18.2.99","article-title":"Antinociceptive effect of the intrathecal phosphodiesterase inhibitor, zaprinast, in a rat formalin test","volume":"18","author":"Heo","year":"2005","journal-title":"Korean J Pain"},{"key":"10.1016\/j.pharep.2018.10.002_bib0450","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2015.05.058","article-title":"IL-1 receptor antagonist improves morphine and buprenorphine effi- cacy in a rat neuropathic pain model","volume":"764","author":"Pilat","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.002_bib0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2008.07.005","article-title":"Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice","volume":"23","author":"Mika","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharep.2018.10.002_bib0460","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.04.024","article-title":"Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - evidence from in vivo and in vitro studies","volume":"108","author":"Piotrowska","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:46Z","timestamp":1752611866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.10.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1734114018303414"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}